CN103100076B - Medicament for treating eczema - Google Patents
Medicament for treating eczema Download PDFInfo
- Publication number
- CN103100076B CN103100076B CN201310071142.2A CN201310071142A CN103100076B CN 103100076 B CN103100076 B CN 103100076B CN 201310071142 A CN201310071142 A CN 201310071142A CN 103100076 B CN103100076 B CN 103100076B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- fructus
- radix
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a medicament for treating eczema. The medicament is prepared from the following substances in parts by weight: 5-10 parts of figwort root, 10-20 parts of dried ginger, 20-30 parts of dogwood fruit, 10-20 parts of balloonflower root, 15-25 parts of dahurian angelica root, 5-15 parts of inula flower, 10-30 parts of purslane, 1-15 parts of dutchmanspipe vine, 10-20 parts of ledebouriella root, 15-30 parts of ark shell, 20-30 parts of belleric terminalia fruit, 1-20 parts of morinda root, 1-20 parts of barbat skullcap, 10-25 parts of cogongrass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of natural indigo, 10-20 parts of cardamom, 15-20 parts of herba inulae, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of muskmelon seed, 5-15 parts of climbing fern spore, 1-20 parts of herba ecliptae, 15-25 parts of dahurian rhododendron leaf, 10-20 parts of rhizoma pleionis, 10-30 parts of herba glechomae, 1-15 parts of oyster, 15-20 parts of snake slough and 5-15 parts of lotus seed. According to the medicament for treating eczema, disclosed by the invention, all ingredients are natural materials, the safety performance is better, and the curative effect is clear, so that the medicament is suitable for being clinically popularized in a large scale.
Description
Technical field
The present invention relates to Pharmacy department field, relate in particular to a kind of medicament for the treatment of eczema.
Background technology
Eczema is that the inflammatory skin of a kind of common epidermis being caused by multiple internal and external factor and high dermis is sick, it is generally acknowledged with allergy and has certain relation.Its clinical manifestation has the features such as symmetry, exudative, itching skin disease, pleomorphism and recurrent.Eczema is a kind of dermatosis of easy recurrence, treatment needs recurrent medicine dedicated, as the medicine that contains the clean skin composition of health, be also a kind of allergic inflammation dermatoses with erythra multiformity, it is feature that symmetrical, violent pruritus shows effect, easily develops into chronic repeatedly.Can betide any position of any age, in any season, but recur or aggravate the winter of being everlasting, have the tendency of oozing out, the chronic course of disease, easily outbreak repeatedly.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of eczema.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of eczema, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Herba Portulacae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Concha Arcae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Scutellariae Barbatae 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Indigo Naturalis 15-20 part, Fructus Amomi Rotundus 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Semen Melo 10-25 part, Spora Lygodii 5-15 part, Herba Ecliptae 1-20 part, Folium Rhododendri Daurici 15-25 part, Pseudobulbus Cremastrae Seu Pleiones 10-20 part, Herba Glechomae 10-30 part, Concha Ostreae 1-15 part, Periostracum Serpentis 15-20 part and Semen Nelumbinis 5-15 part.
Preferably, the medicament for the treatment of eczema of the present invention is to be made by the material of following weight proportioning: 9 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 24 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 24 parts of the Radixs Angelicae Dahuricae, 11 parts of Flos Inulaes, 27 parts of Herba Portulacaes, 4 parts of Herba Aristolochiaes, 15 parts of Radix Saposhnikoviaes, 24 parts of Concha Arcaes, 23 parts of Fructus Terminaliae Billericaees, 16 parts of Radix Morindae Officinaliss, 15 parts of Herba Scutellariae Barbataes, 21 parts of Rhizoma Imperataes, 27 parts of Fructus Xanthii, 2 parts of Fructus Phyllanthis, 16 parts of Indigo Naturaliss, 14 parts, Fructus Amomi Rotundus, 16 parts of Herba Inulae, 24 parts of Herba Sarcandraes, 13 parts of Herba Clinopodii, 22 parts of Semen Melos, 10 parts of Spora Lygodii, 11 parts of Herba Ecliptaes, 21 parts of Folium Rhododendri Daurici, 13 parts of Pseudobulbus Cremastrae Seu Pleioness, 25 parts of Herba Glechomaes, 5 parts of Concha Ostreaes, 10 parts, 16 parts of Periostracum Serpentiss and Semen Nelumbinis.
More preferably, described medicament is tablet, dispersible tablet, capsule or ointment.
Whole compositions of the medicament for the treatment of eczema of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Below by embodiment, further illustrate the present invention.It should be understood that embodiments of the invention are for the present invention rather than limitation of the present invention are described.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percent otherwise in the present invention is percetage by weight.
Embodiment ointment of the present invention
Take 9 grams of Radix Scrophulariaes, 13 grams of Rhizoma Zingiberiss, 24 grams of Fructus Corni, 15 grams of Radix Platycodoniss, 24 grams of the Radixs Angelicae Dahuricae, 11 grams of Flos Inulaes, 27 grams of Herba Portulacaes, 4 grams of Herba Aristolochiaes, 15 grams of Radix Saposhnikoviaes, 24 grams of Concha Arcaes, 23 grams of Fructus Terminaliae Billericaees, 16 grams of Radix Morindae Officinaliss, 15 grams of Herba Scutellariae Barbataes, 21 grams of Rhizoma Imperataes, 27 grams of Fructus Xanthii, 2 grams of Fructus Phyllanthis, 16 grams of Indigo Naturaliss, 14 grams, Fructus Amomi Rotundus, 16 grams of Herba Inulae, 24 grams of Herba Sarcandraes, 13 grams of Herba Clinopodii, 22 grams of Semen Melos, 10 grams of Spora Lygodii, 11 grams of Herba Ecliptaes, 21 grams of Folium Rhododendri Daurici, 13 grams of Pseudobulbus Cremastrae Seu Pleioness, 25 grams of Herba Glechomaes, 5 grams of Concha Ostreaes, 10 grams, 16 grams of Periostracum Serpentiss and Semen Nelumbinis, pulverize, cross 80 mesh sieves, micronization is pulverized, cross 100 mesh sieves, mix homogeneously.To adding 340 grams, 200 grams of liquid paraffin and vaseline in the above-mentioned powder mixing, be stirred to and be even paste, obtain.
Experimental example
30 examples all meet the diagnostic criteria of < < clinical dermatology > > eczema (Zhao debates. clinical dermatology [M]. the 3rd edition. Nanjing: Jiangsu science tech publishing house, 2001.605.).Man's 19 examples, female's 11 examples; Age 27-74 year, average 47.6 years old; The course of disease 3 months-10 years, average 1.5 years; Forethiga eczema 6 examples, the back of the hand portion eczema 4 examples, buttocks eczema person 1 example, huckle eczema person 7 examples, legs eczema person 9 examples, dorsal portion eczema 3 examples.Show as skin lesion and be pleomorphism, be apt to occur in face, hands, foot, shank, visible red mottle or dark red mottle, pimple, vesicle, ooze out, rotten to the corn etc., visible pustule, pus crusts during secondary infection, acute pruritus, accompanies vexed, thirsty, constipation, red tongue yellow fur, slippery and rapid pulse.
Use the ointment of preparation in embodiment 1 to treat for above-mentioned patient, to be evenly applied to affected part, be as the criterion, one day twice, 20 grams of each every place coatings, seven days were a course for the treatment of.
Criterion of therapeutical effect
Recovery from illness: erythra all disappears, and only leaves over pigmentation, pruritus transference cure, follows up a case by regular visits to not recurrence in 1 year.Effective: erythra obviously disappears or major part disappears, and pruritus obviously alleviates, even in 1 year have recurrence, but symptom is slight, and skin lesion is front minimizing.Effective: erythra partly disappears, symptom takes a turn for the better, and has slight pruritus.Invalid: erythra is without disappearing or symptom increases the weight of.
30 routine patients are after treating 1 course for the treatment of, and the erythra of all patients all disappears, and only leave over pigmentation, pruritus transference cure.And follow up a case by regular visits to not recurrence in 1 year.
Claims (2)
1. an ointment for the treatment of eczema, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Herba Portulacae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Concha Arcae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Scutellariae Barbatae 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Indigo Naturalis 15-20 part, Fructus Amomi Rotundus 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Semen Melo 10-25 part, Spora Lygodii 5-15 part, Herba Ecliptae 1-20 part, Folium Rhododendri Daurici 15-25 part, Pseudobulbus Cremastrae Seu Pleiones 10-20 part, Herba Glechomae 10-30 part, Concha Ostreae 1-15 part, Periostracum Serpentis 15-20 part and Semen Nelumbinis 5-15 part.
2. the ointment for the treatment of eczema according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 9 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 24 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 24 parts of the Radixs Angelicae Dahuricae, 11 parts of Flos Inulaes, 27 parts of Herba Portulacaes, 4 parts of Herba Aristolochiaes, 15 parts of Radix Saposhnikoviaes, 24 parts of Concha Arcaes, 23 parts of Fructus Terminaliae Billericaees, 16 parts of Radix Morindae Officinaliss, 15 parts of Herba Scutellariae Barbataes, 21 parts of Rhizoma Imperataes, 27 parts of Fructus Xanthii, 2 parts of Fructus Phyllanthis, 16 parts of Indigo Naturaliss, 14 parts, Fructus Amomi Rotundus, 16 parts of Herba Inulae, 24 parts of Herba Sarcandraes, 13 parts of Herba Clinopodii, 22 parts of Semen Melos, 10 parts of Spora Lygodii, 11 parts of Herba Ecliptaes, 21 parts of Folium Rhododendri Daurici, 13 parts of Pseudobulbus Cremastrae Seu Pleioness, 25 parts of Herba Glechomaes, 5 parts of Concha Ostreaes, 10 parts, 16 parts of Periostracum Serpentiss and Semen Nelumbinis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310071142.2A CN103100076B (en) | 2013-03-07 | 2013-03-07 | Medicament for treating eczema |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310071142.2A CN103100076B (en) | 2013-03-07 | 2013-03-07 | Medicament for treating eczema |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103100076A CN103100076A (en) | 2013-05-15 |
CN103100076B true CN103100076B (en) | 2014-03-26 |
Family
ID=48308488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310071142.2A Expired - Fee Related CN103100076B (en) | 2013-03-07 | 2013-03-07 | Medicament for treating eczema |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103100076B (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102266486A (en) * | 2011-07-27 | 2011-12-07 | 陈忠和 | Medicament for desensitizing, eliminating rashes and removing sores |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101716291B (en) * | 2009-11-17 | 2011-05-04 | 王茂基 | Oral traditional Chinese medicine for treating skin diseases |
-
2013
- 2013-03-07 CN CN201310071142.2A patent/CN103100076B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102266486A (en) * | 2011-07-27 | 2011-12-07 | 陈忠和 | Medicament for desensitizing, eliminating rashes and removing sores |
Also Published As
Publication number | Publication date |
---|---|
CN103100076A (en) | 2013-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102205078B (en) | High-efficiency compound lightyellow sophora root lotion and preparation method thereof | |
CN103341145B (en) | Traditional Chinese medicine for treating psoriasis and preparation method thereof | |
CN103100075B (en) | Medicament for treating eczema | |
CN102872241A (en) | Traditional Chinese medicinal composition for treating inflammatory dermatosis and preparation thereof | |
WO2018137319A1 (en) | Application of sarcococca vagans, chinese medicinal ointment for treating skin disease, preparation method and application thereof | |
CN102824477A (en) | Traditional Chinese medicine paste for treating dermatosis | |
CN103100076B (en) | Medicament for treating eczema | |
CN101843861B (en) | Chinese medicinal composition for treating tonsillitis | |
CN102327460B (en) | Medicament for treating eczema | |
CN103877250B (en) | A kind ofly treat Chinese medicine composition of skin eczema pruritus and preparation method thereof | |
CN101612203B (en) | Traditional Chinese medicine composition used for treating pointed condyloma and application thereof | |
CN102935218B (en) | Traditional Chinese medicine composition for treating decubitus in clinical care | |
CN102940794B (en) | Traditional Chinese medicine for treating eczema and preparation method thereof | |
CN101780179B (en) | Multifunctional plant composition and application thereof as well as multifunctional plant extractive composition, application and antibiotic composition thereof | |
CN102579789B (en) | Medicine for treating eczema | |
CN101708294B (en) | Medicinal composition for treating dermatosis chronic disease and preparation method thereof | |
CN102716217B (en) | Medicine composition for treating acne | |
CN106728455A (en) | A kind of externally used Mongolian medicine composition for treating dermatitis, eczema and preparation method thereof | |
CN104984231A (en) | Traditional Chinese medicine for treating malaria | |
CN105288517A (en) | Traditional Chinese medicine lotion for treating anal fissure | |
CN103142960B (en) | Medicament for treating skin diseases | |
CN104225343A (en) | Chinese herbal preparation for treating urinary tract infection and preparation method thereof | |
CN103920143B (en) | Chinese lobelia spray for resisting oral helicobacter pylori | |
CN102988805B (en) | Traditional Chinese medicine composition for treating allergic purpura | |
CN103393729A (en) | Stranguria relieving and calculus eliminating powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140326 Termination date: 20150307 |
|
EXPY | Termination of patent right or utility model |